Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

Hormonal Control of the Ovarian Cycle

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluating the role of follicular output rate in clinical and embryological outcomes in IVF: a prospective study.

Archives of gynecology and obstetrics·2026

Same author

Effect of ESR1 and ESR2 polymorphisms on ovarian response in assisted reproductive technology cycles: a systematic review and meta-analysis.

Scientific reports·2026

Same author

Exploring the role of social media and online communities in the infertility journey: a scoping review.

Journal of psychosomatic obstetrics and gynaecology·2026

Same author

Variations in serum ferritin levels in women with polycystic ovarian syndrome undergoing assisted reproduction.

Journal of Taibah University Medical Sciences·2026

Same author

Three-Dimensional ultrasound parameters in assessing endometrial receptivity: a prospective study of novel scoring systems in frozen embryo transfer cycles.

Human fertility (Cambridge, England)·2026

Same author

Effect of Reflexology on Menopausal Problems and Quality of Life: A Scoping Review.

Advances in mind-body medicine·2026

Search research articles

Related Experiment Video

Updated: Sep 2, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Random Start Ovarian Stimulation.

Pratap Kumar¹, Shubha Rao¹, Anjali Mundkur¹

¹Department of Reproductive Medicine and Surgery, Kasturba Medical College, MAHE University, Manipal, Karnataka, India.

Journal of Human Reproductive Sciences

|August 5, 2022

Summary

This summary is machine-generated.

Fertility preservation offers options for cancer patients and those with benign conditions. This case report explores applying established fertility preservation protocols to novel indications, expanding its potential applications.

Keywords:

Breast cancer fertility preservation hysterectomy oocytes ovarian stimulation random start

More Related Videos

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Mouse Round Spermatid Injection

Mouse Round Spermatid Injection

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Sep 2, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Mouse Round Spermatid Injection

Mouse Round Spermatid Injection

Published on: January 26, 2024

Area of Science:

Reproductive medicine
Oncology
Gynecology

Background:

Fertility preservation is increasingly recognized as a crucial option for patients facing gonadotoxic treatments or medical conditions impacting fertility.
Established protocols primarily cater to cancer patients and individuals with specific benign conditions requiring fertility preservation.
The adaptability of these protocols for alternative indications remains an area for exploration.

Observation:

This case report details the application of a standard fertility preservation protocol.
The protocol was utilized for indications beyond the typical cancer-related or common benign conditions.
The objective was to assess the feasibility and outcomes of using this protocol in a novel context.

Findings:

The study successfully implemented an existing fertility preservation protocol.
The protocol was adapted for specific, less common indications, demonstrating its versatility.
Outcomes related to the application of the protocol in these new indications were documented.

Implications:

This case report suggests that established fertility preservation techniques may be applicable to a broader range of patient indications.
Expanding the use of fertility preservation protocols could benefit a wider patient population facing fertility-related challenges.
Further research is warranted to validate the efficacy and safety of these protocols across diverse indications.